发明名称 Pramipexole once-daily dosage form
摘要 An orally deliverable pharmaceutical composition comprises a therapeutically effective amount of pramipexole or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient, said composition exhibiting at least one of (a) an in vitro release profile wherein on average no more than about 20% of the pramipexole is dissolved within 2 hours after placement of the composition in a standard dissolution test; and (b) an in vivo pramipexole absorption profile following single dose administration to healthy adult humans wherein the time to reach a mean of 20% absorption is greater than about 2 hours and/or the time to reach a mean of 40% absorption is greater than about 4 hours. The composition is useful for oral administration, not more than once daily, to a subject having a condition or disorder for which a dopamine receptor agonist is indicated.
申请公布号 US8679533(B2) 申请公布日期 2014.03.25
申请号 US20030626275 申请日期 2003.07.24
申请人 LEE ERNEST J.;BREDAEL GERARD M.;BALDWIN JOHN R.;COX STEVEN R.;HEINTZ MARK J.;PHARMACIA CORPORATION 发明人 LEE ERNEST J.;BREDAEL GERARD M.;BALDWIN JOHN R.;COX STEVEN R.;HEINTZ MARK J.
分类号 A61K9/22;A61K9/20;A61K9/28;A61K9/32;A61K31/426;A61K31/428;A61K31/4745;A61P25/16;A61P43/00 主分类号 A61K9/22
代理机构 代理人
主权项
地址